IN2014DN02947A - - Google Patents

Info

Publication number
IN2014DN02947A
IN2014DN02947A IN2947DEN2014A IN2014DN02947A IN 2014DN02947 A IN2014DN02947 A IN 2014DN02947A IN 2947DEN2014 A IN2947DEN2014 A IN 2947DEN2014A IN 2014DN02947 A IN2014DN02947 A IN 2014DN02947A
Authority
IN
India
Prior art keywords
branched
straight
group
hydrogen
alkyl group
Prior art date
Application number
Other languages
English (en)
Inventor
Matthew Cooper
Johannes Zuegg
Bernd Becker
Karoli Tomislav
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Publication of IN2014DN02947A publication Critical patent/IN2014DN02947A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2947DEN2014 2011-09-15 2012-09-14 IN2014DN02947A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11181388A EP2570413A1 (en) 2011-09-15 2011-09-15 Benzothiazinone derivatives as anti-tuberculosis agents
PCT/IB2012/001788 WO2013038259A1 (en) 2011-09-15 2012-09-14 Benzothiazinone derivatives as anti -tuberculosis agents

Publications (1)

Publication Number Publication Date
IN2014DN02947A true IN2014DN02947A (enExample) 2015-05-15

Family

ID=47076272

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2947DEN2014 IN2014DN02947A (enExample) 2011-09-15 2012-09-14

Country Status (4)

Country Link
EP (1) EP2570413A1 (enExample)
AU (1) AU2012310242A1 (enExample)
IN (1) IN2014DN02947A (enExample)
WO (1) WO2013038259A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
CN103508980B (zh) * 2012-06-14 2016-07-06 四川大学 苯并噻嗪-4-酮衍生物及其制备方法和用途
CN105622596B (zh) * 2016-02-19 2018-10-30 浙江司太立制药股份有限公司 含有烷氧亚胺基氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法
CN105669664B (zh) * 2016-02-19 2019-05-10 浙江司太立制药股份有限公司 含有碱性氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法
CN108929329B (zh) * 2017-05-24 2020-12-11 中国医学科学院药物研究所 2-氮杂环-5-三氟甲基-8-硝基苯并(硫代)吡喃-4-酮类化合物
CN108947952B (zh) * 2017-05-24 2021-09-21 中国医学科学院药物研究所 2-取代氨基-5-三氟甲基-8-硝基苯并(硫代)吡喃-4-酮类化合物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007134625A1 (en) 2006-05-24 2007-11-29 Leibniz Institute For Natural Product Research And Infection Biology E.V. Hans-Knöll-Institut (Hki) New benzothiazinone derivatives and their use as antibacterial agents
EP2020406A1 (en) 2007-07-16 2009-02-04 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut New antimicrobial compounds, their synthesis and their use for treatment of mammalian infection

Also Published As

Publication number Publication date
WO2013038259A1 (en) 2013-03-21
EP2570413A1 (en) 2013-03-20
AU2012310242A1 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
IN2014DN02947A (enExample)
WO2013121449A8 (en) Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases
MX2012009186A (es) Pirrolidina-2-carboxamidas sustituidas.
PH12017501192B1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
PH12016502037A1 (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
TN2011000400A1 (en) Inhibitors of beta-secretase
WO2011039221A3 (en) Phosphoramidate derivatives of nucleosides
GEP201606507B (en) Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
MX2013003019A (es) Compuestos de azabenzotiazol, composiciones y metodos de uso.
WO2010091892A3 (en) Alkylamido compounds and uses thereof
MX2014016037A (es) Metodo para usar acidos ftalico y tereftalico y derivados de los mismos en operaciones de tratamientos de pozos.
MX2009009238A (es) Nuevos inhibidores de fosfodiesterasa.
NZ597376A (en) Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
MX2015007883A (es) Compuestos para protección de células.
EA201391558A1 (ru) Тетрагидропиразоло[1,5-а]пиримидины как противотуберкулезные соединения
MY150437A (en) Hydroxamate-based inhibitors of deacetylases b
IN2014MN01521A (enExample)
PL1753723T3 (pl) Podstawione pochodne chinoliny jako inhibitory kinezyn mitotycznych
AR073117A1 (es) Derivado de aminometil-fenil-piperidin-1-il-indolil-metanona, inhibidores de la triptasa de mastocitos, composiciones farmaceuticas que lo contienen, metodo de preparacion, compuestos intermediarios y uso del compuesto en el tratamiento de procesos inflamatorios.
WO2012103071A3 (en) Compounds and compositions
WO2012117357A3 (en) Process for preparation of ketolide intermediates
GEP20125548B (en) New dihidroindolone compounds, a process for its preparation and pharmaceutical compositions containing them
MY146939A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
MX2011012068A (es) Nucleosidos 2'-fluoro arabino y su utilizaicon.
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors